Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 51.39%.

  • Beta Bionics' EBITDA Margin rose 64200.0% to 51.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 87.55%, marking a year-over-year change of. This contributed to the annual value of 84.19% for FY2024, which is 2823100.0% up from last year.
  • As of Q3 2025, Beta Bionics' EBITDA Margin stood at 51.39%, which was up 64200.0% from 72.98% recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' EBITDA Margin peaked at 51.39% during Q3 2025, and registered a low of 161.47% during Q1 2025.